The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Lynn Million
Radiation oncologist
Practice Areas
Professional Education
- Fellowship: Stanford University - Radiation Oncology (1991) CA
- Residency: Stanford University - Radiation Oncology (1990) CA
- Internship: Georgia Baptist Medical Center (1987) GA
- Board Certification: Radiation Oncology, American Board of Radiology (1991)
- Medical Education: University of Florida (1986) FL
Publications
-
Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma.
Gratzinger, D., Million, L., & Kim, Y. H. (2015). Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma. American Journal of dermatopathology, 37(10), 767-770. -
Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials
Hoppe, R. T., Harrison, C., Tavallaee, M., Bashey, S., Sundram, U., & Kim, Y. H. (2015). Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(2), 286-292. -
Successful Treatment with Temozolomide Combined with Chemoradiotherapy and Surgery of a Metastatic Undifferentiated Soft Tissue Sarcoma with Relapse in the Central Nervous System of a Young Adult
Hsu, C. H., Daldrup-Link, H. E., Yeom, K. W., Donaldson, S. S., Million, L., & Rangaswami, A. (2014). Successful Treatment with Temozolomide Combined with Chemoradiotherapy and Surgery of a Metastatic Undifferentiated Soft Tissue Sarcoma with Relapse in the Central Nervous System of a Young Adult. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 3(2), 100-103. -
Survival and Neurocognitive Outcomes After Cranial or Craniospinal Irradiation Plus Total-Body Irradiation Before Stem Cell Transplantation in Pediatric Leukemia Patients With Central Nervous System Involvement
Hiniker, S. M., Agarwal, R., Modlin, L. A., Gray, C. C., Harris, J. P., & Donaldson, S. S. (2014). Survival and Neurocognitive Outcomes After Cranial or Craniospinal Irradiation Plus Total-Body Irradiation Before Stem Cell Transplantation in Pediatric Leukemia Patients With Central Nervous System Involvement. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(1), 67-74.
-
Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: A report from the Children's Oncology Group
Raney, B., Huh, W., Hawkins, D., Hayes-Jordan, A., Million, L., & Anderson, J. (2013). Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: A report from the Children's Oncology Group. PEDIATRIC BLOOD & CANCER, 60(3), 371-376.
-
Is Tanning Bed Exposure Associated With Aggressive Basal Cell Carcinoma?
Gamba, C. A., Wysong, A., Million, L., Aasi, S., Kim, J., & Tang, J. Y. (2012). Is Tanning Bed Exposure Associated With Aggressive Basal Cell Carcinoma?. JOURNAL OF CLINICAL ONCOLOGY, 30(32), E333-E336.
-
Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome
Henry, E., Villalobos, V., Million, L., Jensen, K. C., West, R., & Telli, M. L. (2012). Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(8), 939-942.
-
Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma: which patients benefit from adjuvant radiation therapy and how much?
Million, L., & Donaldson, S. S. (2012). Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma: which patients benefit from adjuvant radiation therapy and how much?. ISRN oncology, 2012, 341408-?.
-
INFLUENCE OF NONCOMPLIANCE WITH RADIATION THERAPY PROTOCOL GUIDELINES AND OPERATIVE BED RECURRENCES FOR CHILDREN WITH RHABDOMYOSARCOMA AND MICROSCOPIC RESIDUAL DISEASE: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Million, L., Anderson, J., Breneman, J., Hawkins, D. S., Laurie, F., & Donaldson, S. S. (2011). INFLUENCE OF NONCOMPLIANCE WITH RADIATION THERAPY PROTOCOL GUIDELINES AND OPERATIVE BED RECURRENCES FOR CHILDREN WITH RHABDOMYOSARCOMA AND MICROSCOPIC RESIDUAL DISEASE: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 80(2), 333-338.
-
Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma: Results From IRS-IV and D9803-A Report From the Children's Oncology Group
Minn, A. Y., Lyden, E. R., Anderson, J. R., Million, L., Arndt, C. A., & Donaldson, S. S. (2010). Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma: Results From IRS-IV and D9803-A Report From the Children's Oncology Group. JOURNAL OF CLINICAL ONCOLOGY, 28(27), 4228-4232.
-
Undifferentiated High-Grade Pleomorphic Sarcomas in Children: A Clinicopathologic Study of 10 Cases and Review of Literature
Alaggio, R., Collini, P., Randall, R. L., Barnette, P., Million, L., & Coffin, C. M. (2010). Undifferentiated High-Grade Pleomorphic Sarcomas in Children: A Clinicopathologic Study of 10 Cases and Review of Literature. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 13(3), 209-217.
-
Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: a report from the children's oncology group.
Rodeberg, D. A., Stoner, J. A., Garcia-Henriquez, N., Randall, R. L., Spunt, S. L., & Hawkins, D. S. (2010). Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: a report from the children's oncology group. Cancer.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Jul 2015
Very good.
SHC Patient, Jul 2015
Dr. Million's complete & clear discussion about my serious medical condition was very appreciated. Her explanations & thought process were clear and easy to understand for myself & my husband.
SHC Patient, May 2015
I recommend your doctors & facility to every one I know.
SHC Patient, Mar 2015
Dr. Million is a wonderful doctor! I am so lucky and grateful to have her as a provider.
SHC Patient, Jan 2015
Although I have high confidence in where we are headed, I would like to have been asked if I had any questions and reassured that ultimately I had the choice of what treatment I wanted to undergo.
SHC Patient, Dec 2014
Good.
SHC Patient, Nov 2014
Dr. Million is exceptional! Caring, knowledgeable and empathetic - The best.
SHC Patient, Jan 2014
Dr. Million is excellent! Compassionate, excellent clinician.
SHC Patient, Jul 2015
Very good.
SHC Patient, Jul 2015
Dr. Million's complete & clear discussion about my serious medical condition was very appreciated. Her explanations & thought process were clear and easy to understand for myself & my husband.
SHC Patient, May 2015
I recommend your doctors & facility to every one I know.
SHC Patient, Mar 2015
Dr. Million is a wonderful doctor! I am so lucky and grateful to have her as a provider.
SHC Patient, Jan 2015
Although I have high confidence in where we are headed, I would like to have been asked if I had any questions and reassured that ultimately I had the choice of what treatment I wanted to undergo.
SHC Patient, Dec 2014
Good.
SHC Patient, Nov 2014
Dr. Million is exceptional! Caring, knowledgeable and empathetic - The best.
SHC Patient, Jan 2014
Dr. Million is excellent! Compassionate, excellent clinician.